acebutolol has been researched along with Pulmonary Hypertension in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alonso-Gonzalez, R; Beghetti, M; Blanche, C; Dimopoulos, K; Kempny, A; Price, L; Swan, L; Uribarri, A; Wort, SJ | 1 |
| Baldus, S; Dumitrescu, D; Gerhardt, F; Knoop-Busch, S; Rosenkranz, S; Rudolph, TK; ten Freyhaus, H; Viethen, T | 1 |
| Alavian, KN; Ashek, A; Bozorgi, S; Busbridge, M; Cotroneo, E; Dubois, O; Wang, L; Wharton, J; Wilkins, MR; Zhao, L | 1 |
3 other study(ies) available for acebutolol and Pulmonary Hypertension
| Article | Year |
|---|---|
Use of intravenous iron in cyanotic patients with congenital heart disease and/or pulmonary hypertension.
Topics: Administration, Intravenous; Adult; Aged; Drug Monitoring; Erythropoiesis; Female; Ferric Compounds; Heart Defects, Congenital; Hematinics; Hematologic Tests; Humans; Hypertension, Pulmonary; Iron; Iron Deficiencies; Male; Maltose; Middle Aged; Polycythemia; Retrospective Studies; Treatment Outcome; United Kingdom | 2018 |
Ferric carboxymaltose improves exercise capacity and quality of life in patients with pulmonary arterial hypertension and iron deficiency: a pilot study.
Topics: Aged; Anemia, Iron-Deficiency; Exercise Test; Female; Ferric Compounds; Humans; Hypertension, Pulmonary; Infusions, Intravenous; Male; Maltose; Middle Aged; Pilot Projects; Prospective Studies; Quality of Life | 2014 |
Iron homeostasis and pulmonary hypertension: iron deficiency leads to pulmonary vascular remodeling in the rat.
Topics: Animals; Antihypertensive Agents; Arterial Pressure; Benzamides; Cell Proliferation; Deficiency Diseases; Dichloroacetic Acid; Disease Models, Animal; Erythropoiesis; Ferric Compounds; Ferritins; Glycolysis; Hematinics; Homeostasis; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Imatinib Mesylate; Iron; Iron Deficiencies; Liver; Male; Maltose; Piperazines; Pulmonary Artery; Pyrimidines; Rats, Sprague-Dawley; Signal Transduction; Time Factors; Transferrin; Vascular Remodeling | 2015 |